Chufengjing

Chufengjing is a Traditional Chinese Medicine (TCM) preparation developed and manufactured by Shandong Hongjitang Pharmaceutical. It is a classic formulation categorized under the company's 'Secondary Development of Old/Established Drugs' initiative, which focuses on 'cultivating major varieties' through modern clinical research and quality standard enhancement. Historically, Chufengjing is indicated for the treatment of 'Wind-Cold-Dampness Bi-syndrome,' a TCM classification that encompasses conditions such as rheumatoid arthritis, joint pain, muscle aches, and numbness of the limbs. The preparation works by dispelling pathogenic wind, cold, and dampness while simultaneously promoting blood circulation to alleviate pain and restore mobility. As an established product in Hongjitang's portfolio, it represents the integration of traditional therapeutic wisdom with contemporary pharmaceutical development goals.

Brand names

Chufengjing

Other names

Chu Feng Jing